Literature DB >> 13995378

Preparation and properties of a freeze-dried B.C.G. vaccine of increased stability.

J UNGAR, P W MUGGLETON, J A DUDLEY, M I GRIFFITHS.   

Abstract

Keywords:  BCG VACCINATION; FREEZE DRYING; MYCOBACTERIUM BOVIS; VACCINES

Mesh：

Substances：

Year:  1962        PMID： 13995378      PMCID： PMC1926490          DOI： 10.1136/bmj.2.5312.1086

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Effect of adjuvant on preservability of dried BCG vaccine at 37 degrees C.

Authors:  C CHO; Y OBAYASHI
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

2.  Freeze-dried B.C.G. vaccine; methods adopted in preparation of a standard product.

Authors:  P FARMER; P W MUGGLETON; J UNGAR
Journal:  Br Med J       Date:  1956-09-08

3.  Freezedried B.C.G.; vaccination of newborn infants with a British vaccine.

Authors:  W GAISFORD; M I GRIFFITHS
Journal:  Br Med J       Date:  1956-09-08

4.  Studies on the stability of lyophilized B C G vaccine.

Authors:  R MILLER; K GOODNER
Journal:  Yale J Biol Med       Date:  1953-02
  4 in total
  9 in total

1.  B.C.G. BY JET INJECTOR.

Authors:  M CAPLIN; L H CAPEL; W F WHEELER
Journal:  Br Med J       Date:  1965-08-21

2.  Galactosamine in walls of slow-growing mycobacteria.

Authors:  P Draper; K H Khoo; D Chatterjee; A Dell; H R Morris
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

3.  Size characterization of Mycobacterium bovis BCG (Bacillus Calmette Guérin) vaccine, Tice substrain.

Authors:  A Zhang; M J Groves
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

4.  A co-operative evaluation of test systems used to assay tuberculosis vaccines.

Authors:  E H Wiegeshaus; G Harding; D McMurray; A A Grover; D W Smith
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

5.  Serial subcultivation of Czechoslovakian and Japanese BCG strains.

Authors:  T W Osborn
Journal:  J Hyg (Lond)       Date:  1980-10

6.  Stabilization of a recombinant ricin toxin A subunit vaccine through lyophilization.

Authors:  Kimberly J Hassett; Megan C Cousins; Lilia A Rabia; Chrystal M Chadwick; Joanne M O'Hara; Pradyot Nandi; Robert N Brey; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  Eur J Pharm Biopharm       Date:  2013-04-10       Impact factor: 5.571

7.  Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.

Authors:  W H de Jong; P A Steerenberg; J G Kreeftenberg; R H Tiesjema; W Kruizinga; L M van Noorle Jansen; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

8.  High-viability lyophilized Bacille Calmette-Guérin vaccine produced by deep-culture technique.

Authors:  T H Kim
Journal:  Appl Environ Microbiol       Date:  1977-11       Impact factor: 4.792

9.  Activation of the alternative pathway of complement by mycobacteria and cord factor.

Authors:  V D Ramanathan; J Curtis; J L Turk
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.